Latest Lipigon News & Updates

See the latest news and media coverage for Lipigon. We track all announcements, press releases, and industry mentions in real time, all in one place.

Lipigon

Biotechnology company developing treatments for lipid and lung diseases

lipigon.se

Headquarters: Umeå, Sweden
Founded year: 2010
Company type: Public company
Number of employees: 7–10
Industry: Pharmaceuticals

Last updated May 17

Latest news about Lipigon

In short: Lipigon appointed new CEO Mikael Gustavsson and refocused on lung diseases while facing Nasdaq delisting.

Company announcements

May 4 Lipigon

Nasdaq delists Lipigon from First North Growth Market

The share is traded until and including 18 May 2026. The decision is motivated by the company not meeting the requirement for ongoing operations after phase II results.

April 20 Lipigon

Lipigon’s board withdraws delisting proposal

Nasdaq Stockholm initiates separate delisting process after phase II results. Last trading day expected May 18, 2026.

April 15 Lipigon

Lipigon's board proposes delisting from Nasdaq First North

The proposal is motivated by costs and strategic flexibility. CEO Johan Liwing terminates his agreement. AGM is held on May 18, 2026.

March 26 Lipigon

Lipigon publishes year-end report 2025

Reports phase II results for Lipisense®, cost savings and financial overview with operating result -32 218 tkr. Strategic review ongoing.

Media coverage

May 17 Investing.com

Lipigon Pharmaceuticals AB (LPGO)

Lipigon Pharmaceuticals AB has a price-to-earnings (P/E) ratio of -0.070 (TTM). This compares to an industry average of 27.959. What is Lipigon Pharmaceuticals AB’s price-to-sales...

April 13 EurekAlert!

NTU Singapore, SUSTech and pharmaceutical firm Lipigon develop inhaled therapy to reduce lung damage from severe infections

Nanyang Technological University, Singapore (NTU Singapore) is working with China’s Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB to...

February 17 Life Sciences Sweden

Umeå company in turmoil after miss in study

A miscalculation in a clinical study has put Umeå-based Lipigon Pharmaceuticals under hard pressure. A strategic review of the company is ongoing, and the board does not rule out that...

March 26, 2025 AffärsVärlden

Emissionsguiden initiates coverage of Lipigon's rights issue

Lipigon Pharmaceuticals' board of directors has decided on a rights issue that needs to be voted through at an extraordinary general meeting on April 28. Lipigon Pharmaceuticals develops treatments against so...

Never miss news about Lipigon

Track Lipigon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Lipigon competitors & trending companies

Browse news for competitors to Lipigon and other trending companies.